Medtronic Plc Stock Filter Stocks by Fundamentals
MDT Stock | USD 80.38 0.91 1.12% |
Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.
Medtronic | Shares Owned by Insiders |
Medtronic PLC ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Medtronic PLC Institutional Holders
Institutional Holdings refers to the ownership stake in Medtronic PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medtronic PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medtronic PLC's value.Shares | Franklin Resources Inc | 2023-12-31 | 19.4 M | Deutsche Bank Ag | 2023-12-31 | 17.3 M | T. Rowe Price Associates, Inc. | 2023-12-31 | 15.4 M | Norges Bank | 2023-12-31 | 14.9 M | Wells Fargo & Co | 2023-12-31 | 13.1 M | Northern Trust Corp | 2023-12-31 | 12.7 M | Sanders Capital, Llc | 0055-12-31 | 12.6 M | Royal Bank Of Canada | 2023-12-31 | 12.6 M | Goldman Sachs Group Inc | 2023-12-31 | 12 M | Vanguard Group Inc | 2023-12-31 | 126.5 M | Blackrock Inc | 2023-12-31 | 118.6 M |
Medtronic Fundamentals
Return On Equity | 0.0817 | ||||
Return On Asset | 0.0423 | ||||
Profit Margin | 0.13 % | ||||
Operating Margin | 0.19 % | ||||
Current Valuation | 125 B | ||||
Shares Outstanding | 1.33 B | ||||
Shares Owned By Insiders | 0.10 % | ||||
Shares Owned By Institutions | 85.26 % | ||||
Number Of Shares Shorted | 12.43 M | ||||
Price To Earning | 20.44 X | ||||
Price To Book | 2.05 X | ||||
Price To Sales | 3.29 X | ||||
Revenue | 31.23 B | ||||
Gross Profit | 21.71 B | ||||
EBITDA | 9.04 B | ||||
Net Income | 3.78 B | ||||
Cash And Equivalents | 1.54 B | ||||
Cash Per Share | 8.59 X | ||||
Total Debt | 24.36 B | ||||
Debt To Equity | 0.51 % | ||||
Current Ratio | 1.76 X | ||||
Book Value Per Share | 38.95 X | ||||
Cash Flow From Operations | 6.04 B | ||||
Short Ratio | 1.96 X | ||||
Earnings Per Share | 3.15 X | ||||
Price To Earnings To Growth | 1.52 X | ||||
Target Price | 94.0 | ||||
Number Of Employees | 95 K | ||||
Beta | 0.78 | ||||
Market Capitalization | 107.94 B | ||||
Total Asset | 90.95 B | ||||
Retained Earnings | 30.39 B | ||||
Working Capital | 12.62 B | ||||
Current Asset | 23.6 B | ||||
Current Liabilities | 7.17 B | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 2.18 % | ||||
Net Asset | 90.95 B | ||||
Last Dividend Paid | 2.75 |
About Medtronic PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Medtronic PLC Piotroski F Score and Medtronic PLC Altman Z Score analysis. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.